Clinical Trial: ALLIANCE MM1MDS-A01

ALLIANCE MM1MDS-A01

Status: New, Open

A Randomized Phase II Trial of Enasidenib-Based Therapies Versus Cedazuridine-Decitabine in Higher-Risk IDH2-Mutated Myelodysplastic Syndrome: A MyeloMATCH Sub-Study

(See required screening study MYELOMATCH)